Tahereh Ghaziani
University of Connecticut Health Center
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Tahereh Ghaziani.
Hepatology Research | 2007
Tahereh Ghaziani; Seyed Moayed Alavian; Mohammad Reza Zali; Saeid Shahraz; Mohammdreza Agah; Kevin P. Jensen; Shahin Ansari; Hossein Sendi; Richard W. Lambrecht; Jonathan Covault; Herbert L. Bonkovsky
Aim: We tested associations between HFE mutations and hepatitis B virus (HBV) infection. We also explored measures of total body iron status and their association with chronic HBV infection.
BMC Gastroenterology | 2004
Mohammad Reza Zali; Tahereh Ghaziani; Saeed Shahraz; Azita Hekmatdoost; Ali Radmehr
BackgroundFasciola hepatica primarily involves the liver, however in some exceptional situations other organs have been reported to be involved. The ectopic involvement is either a result of Parasite migration or perhaps eosinophilic reaction.Case presentationHere we report a known case of multiple myeloma who was under treatment with prednisolone and melphalan. He was infected by Fasciola hepatica, which involved many organs and the lesions were mistaken with metastatic ones.DiscussionPresented here is a very unusual case of the disease, likely the first case involving the pancreas, spleen, and kidney, as well as the liver.
Alimentary Pharmacology & Therapeutics | 2016
Z. Gordon Jiang; Linda Feldbrügge; Elliot B. Tapper; Yury Popov; Tahereh Ghaziani; Nezam H. Afdhal; Simon C. Robson; Kenneth J. Mukamal
Recent animal studies have shown that platelets directly activate hepatic stellate cells to promote liver fibrosis, whereas anti‐platelet agents decrease liver fibrosis. It is unknown whether platelet inhibition by aspirin prevents liver fibrosis in humans.
Scientific Reports | 2016
Ruoyu Miao; Yan Wu; Haohai Zhang; Huandi Zhou; Xiaofeng Sun; Eva Csizmadia; Lian He; Yi Zhao; Chengyu Jiang; Rebecca A. Miksad; Tahereh Ghaziani; Simon C. Robson; Haitao Zhao
Therapies for primary liver cancer, the third leading cause of cancer-related death worldwide, remain limited. Following multi-omics analysis (including whole genome and transcriptome sequencing), we were able to identify the dual-specific protein kinase TTK as a putative new prognostic biomarker for liver cancer. Herein, we show that levels of TTK protein are significantly elevated in neoplastic tissues from a cohort of liver cancer patients, when compared with adjacent hepatic tissues. We also tested the utility of TTK targeted inhibition and have demonstrated therapeutic potential in an experimental model of liver cancer in vivo. Following lentiviral shRNA knockdown in several human liver cancer cell lines, we demonstrated that TTK boosts cell growth and promotes cell spreading; as well as protects against senescence and decreases autophagy. In an experimental animal model, we show that in vitro knockdown of TTK effectively blocks intrahepatic growth of human HCC xenografts. Furthermore, we note that, in vivo silencing of TTK, by systemically delivering TTK siRNAs to already tumor-bearing liver, limits intrahepatic spread of liver cancer cells. This intervention is associated with decreased tumor aggressiveness, as well as increased senescence and autophagy. Taken together, our data suggest that targeted TTK inhibition might have clinical utility as an adjunct therapy in management of liver cancer.
Clinical Infectious Diseases | 2005
Hossein Sendi; Tahereh Ghaziani; Mohammad Reza Zali; Peyman Adibi; M R Agah; Maryam Jazayeri; Saeed Shahraz; Lars O. Magnius; Herbert L. Bonkovsky
In this study, the frequencies of the common hemochromatosis gene mutations were assessed in 75 Iranian subjects with chronic hepatitis B infection. We found that the major C282Y mutation was significantly more frequent in subjects infected with hepatitis B virus (4%) than in 194 control subjects (0%, P=.02; Fishers exact test).
Alimentary Pharmacology & Therapeutics | 2016
Zhenghui G. Jiang; Linda Feldbrügge; Elliot B. Tapper; Yury Popov; Tahereh Ghaziani; Nezam H. Afdhal; Simon C. Robson; Kenneth J. Mukamal
icantly correlated with reduced odds ratio for advanced fibrosis in suspected ALD. However, although ibuprofen was used as control, one still could not rule out the possibility that patients with advanced fibrosis do not take aspirin for the fear of bleeding for example. The author suggested that aspirin might alleviate progression of liver fibrosis through its anti-platelet function, while alcohol itself can inhibit aggregation of platelets in a dose-dependent manner (for review). On the other hand, there was a study that showed that aspirin could reduce the metabolism of ethanol in the human body and potentially increase the adverse effects of alcohol. A recent study confirmed that aspirin and its metabolite, salicylate, could inhibit activities of human alcohol dehydrogenases including alcohol dehydrogenase and aldehyde dehyrogenase, two principal enzymes responsible for ethanol metabolism. Based on these evidences, effect of aspirin in ALD might be limited. Nevertheless, this article indicated that aspirin might associate with lower liver fibrosis in the human body especially in virus hepatitis and NASH and it greatly expanded our understanding on this issue. Further studies are warranted to confirm this result.
The American Journal of Gastroenterology | 2003
Mohammad Reza Zali; Hamid Reza Sima; Azita Hekmatdoost; Tahereh Ghaziani; Ameneh Mashayekh
Purpose: The association between celiac disease (CD) and autoimmune hepatitis (AIH) has been already reported, but the association between CD and chronic hepatitis B(CHB) is uncertain. In this study, serological screening for CD was performed in patients with AIH and CHB to define the seroprevalence of this association.
Journal of Biological Chemistry | 2004
Ying Shan; Richard W. Lambrecht; Tahereh Ghaziani; Susan E. Donohue; Herbert L. Bonkovsky
Journal of Hepatology | 2006
Tahereh Ghaziani; Ying Shan; Richard W. Lambrecht; Susan E. Donohue; Thomas Pietschmann; Ralf Bartenschlager; Herbert L. Bonkovsky
Iranian Journal of Allergy Asthma and Immunology | 2010
Hamid Reza Sima; Azita Hekmatdoost; Tahereh Ghaziani; Seyed Moayyed Alavian; Ameneh Mashayekh; Mohammadreza Zali